Figure 1.
Flow chart to illustrate the selection of the samples. At baseline, 4185 serum samples were collected. Of these samples, 352 were positive in a latent class analysis (LCA) of three SARS-CoV-2 antibody tests. Of these participants, 319 attended the next two visits, follow up 1 (FU1) and follow up 2 (FU2), with 211 participants not vaccinated at the time of FU2. These 211 participants (blue highlighted box) represent the study collective.